Springworks Therapeutics Share Price Today
(NASDAQ: SWTX)

Name: Springworks Therapeutics Share Price Today (NASDAQ: SWTX) - Springworks Therapeutics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Springworks Therapeutics share price is $37.92 & ₹3,240.83 as on 18 Apr 2025, 2.30 'hrs' IST

$37.92

▲

0.18

(0.48%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Springworks Therapeutics share price in Dollar and Rupees. Guide to invest in Springworks Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Springworks Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Springworks Therapeutics share price movements

Today's Low: $37.35
Today's High: $39.00
$37.92
1.5%
Downside
Day's Volatility :4.23%
Upside
2.77%
52 Weeks Low: $28.21
52 Weeks High: $62.00
$37.92
25.61%
Downside
52 Weeks Volatility :54.5%
Upside
38.84%

Springworks Therapeutics (SWTX) Returns

Period	Springworks Therapeutics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	4.32%	-2.8%	0.0%
6 Months	24.37%	-11.0%	0.0%
1 Year	-5.44%	-1.9%	0.0%
3 Years	-19.52%	-1.5%	-12.9%

Springworks Therapeutics (SWTX) Key Statistics

in dollars & INR

Previous Close	$37.74
Open	$37.57
Today's High	$39.0
Today's Low	$37.35
Market Capitalization	$2.8B
Today's Volume	$1.5M
52 Week High	$62.0
52 Week Low	$28.21
Revenue TTM	$191.6M
EBITDA	$-274.7M
Earnings Per Share (EPS)	$-3.5
Profit Margin	-134.73%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-46.62%

How to invest in Springworks Therapeutics Stock (SWTX) from India?

It is very easy for Indian residents to invest directly in Springworks Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Springworks Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Springworks Therapeutics or SWTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Springworks Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Springworks Therapeutics shares which would translate to 0.023 fractional shares of Springworks Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Springworks Therapeutics, in just a few clicks!

Returns in Springworks Therapeutics (SWTX) for Indian investors in Rupees

The Springworks Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Springworks Therapeutics investment value today

Current value as on today

₹96,905

Returns

₹3,095

(-3.1%)

Returns from Springworks Therapeutics Stock

₹5,436 (-5.44%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Springworks Therapeutics (SWTX)

-47%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Springworks Therapeutics Stock from India on INDmoney has decreased by -47% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Springworks Therapeutics

FMR Inc
14.88%
Vanguard Group Inc
9.55%
BlackRock Inc
7.95%
Deep Track Capital, LP
4.62%
Boxer Capital LLC
4.56%
Boxer Capital Management, LLC
4.56%

Analyst Recommendation on Springworks Therapeutics

Rating

Trend

Buy

93%Buy

6%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Springworks Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Springworks Therapeutics Stock (SWTX)

What analysts predicted

Upside of 92.18%

Target:

$72.88

Current:

$37.92

Insights on Springworks Therapeutics Stock (Ticker Symbol: SWTX)

Price Movement
In the last 3 months, SWTX stock has moved up by 9.0%
Increasing Revenue
Revenue is up for the last 2 quarters, 49.30M → 61.54M (in $), with an average increase of 19.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -39.91M → -77.29M (in $), with an average decrease of 39.3% per quarter
SWTX vs ONC (1 yr)
In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 82.0%
SWTX vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 54.4%
Price to Sales
ForSWTX every $1 of sales, investors are willing to pay $14.7, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

Springworks Therapeutics Technicals Summary

Sell

Neutral

Buy

Springworks Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Springworks Therapeutics (SWTX) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Springworks Therapeutics Inc	-26.12%	24.37%	-5.44%	-19.52%	35.24%
Regeneron Pharmaceuticals, Inc.	-17.1%	-41.85%	-37.2%	-21.74%	-0.85%
Beone Medicines Ltd	-13.12%	5.03%	78.34%	40.23%	43.44%
Vertex Pharmaceuticals Incorporated	-4.76%	2.3%	24.05%	71.43%	78.99%
Alnylam Pharmaceuticals, Inc.	-9.09%	-19.67%	62.43%	39.66%	61.91%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Springworks Therapeutics Inc	NA	NA	NA	-2.42	-0.47	-0.26	NA	6.47
Regeneron Pharmaceuticals, Inc.	14.68	14.68	0.9	41.18	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.09	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.34	17.96	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.81	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Springworks Therapeutics Inc	Buy	$2.8B	35.24%	NA	-134.73%
Regeneron Pharmaceuticals, Inc.	Buy	$60.5B	-0.85%	14.68	31.07%
Beone Medicines Ltd	NA	$26.9B	43.44%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$125.7B	78.99%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$30.4B	61.91%	NA	-12.37%

Springworks Therapeutics Dividend announcements

Springworks Therapeutics Earnings
Springworks Therapeutics’s price-to-earnings ratio stands at None

About Springworks Therapeutics

SpringWorks Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer. It offers OGSIVEO (nirogacestat), an oral small molecule gamma secretase inhibitor for the treatment of desmoid tumors; and GOMEKLI (mirdametinib), an oral small molecule inhibitor of MEK1 and MEK2 for the treatment of adult and pediatric patients two years of age and older with neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN). The company also develops Nirogacestat, is also in Phase 2 clinical development as a monotherapy for the treatment of ovarian granulosa cell tumors (GCT), a subtype of ovarian cancer; and mirdametinib for the treatment of solid tumors harboring other MAPK aberrations, including for the treatment of pediatric and young adult patients with low-grade gliomas that is in Phase 1/2 clinical trial. In addition, its products under development include Brimarafenib (BGB-3245), an oral selective small molecule inhibitor of monomeric and dimeric forms of activating BRAF mutations. The company has license agreements with Pfizer Inc. for nirogacestat and mirdametinib; and Katholieke Universiteit Leuven and the Flanders Institute for Biotechnology for a portfolio of novel small molecule inhibitors of the TEA Domain. SpringWorks Therapeutics, Inc. was founded in 2017 and is headquartered in Stamford, Connecticut.

Organization	Springworks Therapeutics
Employees	368
CEO	Mr. Saqib Islam J.D.
Industry	Health Technology

Management People of Springworks Therapeutics

Name	Title
Mr. Saqib Islam J.D.	CEO & Director
Mr. Francis I. Perier Jr., M.B.A.	Chief Financial Officer
Dr. Badreddin Edris Ph.D.	Chief Operating Officer
Mr. Bhavesh Ashar M.B.A.	Chief Commercial Officer
Dr. James Cassidy M.D., Ph.D.	Chief Medical Officer
Mr. Michael P. Nofi	Chief Accounting Officer
Mr. Tai-An Lin Ph.D.	Chief Scientific Officer
Ms. Kim Diamond	Vice President of Communications & Investor Relations
Mr. Herschel S. Weinstein J.D.	General Counsel & Secretary
Mr. Daniel J. Pichl	Chief People Officer

Important FAQs about investing in SWTX Stock from India :

What is Springworks Therapeutics share price today?

Springworks Therapeutics share price today stands at $37.92, Open: $37.57 ; Previous Close: $37.74 ; High: $39.00 ; Low: $37.35 ; 52 Week High: $62.00 ; 52 Week Low: $28.21.

The stock opens at $37.57, after a previous close of $37.74. The stock reached a daily high of $39.00 and a low of $37.35, with a 52-week high of $62.00 and a 52-week low of $28.21.

Can Indians buy Springworks Therapeutics shares?

Yes, Indians can invest in the Springworks Therapeutics (SWTX) from India.

With INDmoney, you can buy Springworks Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Springworks Therapeutics at zero transaction cost.

How can I buy Springworks Therapeutics shares from India?

It is very easy to buy Springworks Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Springworks Therapeutics (SWTX) be purchased?

Yes, you can buy fractional shares of Springworks Therapeutics with INDmoney app.

What are the documents required to start investing in Springworks Therapeutics stocks?

To start investing in Springworks Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.